Study of the Effect of Serelaxin on High-sensitivity Cardiac Troponin I (Hs-cTnI) Release in Patients With Chronic Heart Failure
Clinical trial NCT02625922 · TERMINATED
Trial details
- NCT number
- NCT02625922
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-05
- Primary completion
- 2017-01-11
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.